USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: Zeigler Bros, Inc.
Address: PO Box 95
Gardners, PA 17324-0095
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $176,415.29 2
SBIR Phase II $397,510.08 1

Award List:

Live Feed Replacement with Nutritionally Complete Manufactured Diets for Emerging Marine Species

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: DOC
Principal Investigator: Tim Markey, Director of Nutrition and Technology
Award Amount: $94,281.73
The culture of emerging marine finfish species is expected to play a major role in the continued expansion of the aquaculture industry. Despite considerable advancements in aquaculture technologies, significant growth of this sector has yet to occur. A major reason for this has been the… More

Development of manufacturing technology for the practical application of specialized and environmentally sensitive nutrients, enzymes, immune-stimulating compounds and biologics to aquafeeds

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: DOC
Principal Investigator: Scott Snyder, Ph.D – (717) 677-3013
Award Amount: $82,133.56
Zeigler Bros., Inc. (ZBI) has teamed with Harrisvaccines, Inc. (HV) to develop a new aquafeed manufacturing platform for the practical application of underutilized feed additives. These include enzymes, immune-stimulating compounds and biologics that require specialized protection to ensure they… More

Development of Manufacturing Technology for the Practical Application of Specialized and Environmentally Sensitive Nutrients, Enzymes, Immune-Stimulating Compounds and Biologics to Aquafeeds

Award Year / Program / Phase: 2013 / SBIR / Phase II
Agency / Branch: DOC / NOAA
Principal Investigator: Matt Zeigler, Vice President of Operations – (717) 677-6181
Award Amount: $397,510.08
In an effort to support the development of a domestic marine aquaculture industry, Zeigler Bros. Inc., (ZBI) proposes to continue its Phase I research by demonstrating the ability to scale up inclusion particle (IP) manufacturing. During Phase II ZBI will also demonstrate the efficacy of IOs for… More